Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
about
A novel toolbox for the in vitro assay of hepatitis D virus infection.Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors.Research progress of therapeutic vaccines for treating chronic hepatitis B.The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication.Antibody-mediated immunotherapy against chronic hepatitis B virus infection.A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsA cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.Antibody therapies for the prevention and treatment of viral infections.Immunotherapy for Chronic Hepatitis B Virus Infection.A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys.Humoral immunity, the underestimated player in hepatitis B.Animal models for the study of hepatitis B virus infection.Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress.The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice.A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infectionOptimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infectionCirculating and intrahepatic antiviral B cells are defective in hepatitis B
P2860
Q37581726-9371DD9C-93F6-41C1-9DAA-CC9498E33024Q39067120-2EEC1430-B064-4601-A115-0C5839EEC06AQ39101021-336F1AEA-CAB6-4578-B763-633B25ADB54EQ40070996-20B122E1-9107-4F92-8357-81DE30E7B8E9Q40196246-A61EC5ED-C9E6-465E-AF91-DA7564806558Q40893286-2F5DB7CF-6FF3-401B-A82A-36CDF1F748BDQ41671765-DF73D3AF-5F4F-4AD4-92EF-F7CFDF051928Q47105994-BC4E94FB-C448-439F-91E3-1F30A65B87FBQ47143843-E8BC2717-F9DA-441E-B366-D8EE0F1D25D5Q47556416-F61A4181-05D5-4894-8421-C5DB52C584B0Q49772736-EA05333F-E4B4-4022-96B2-4062D7E8D0F2Q49962982-DB73331F-5F72-4C60-87B0-E3DA1A986E33Q52671153-B021CC0A-B8BC-4E00-909C-C68963AF0AD0Q52689095-4BA72BF9-3843-45BE-8218-8B268B3A1CD0Q54257015-2888761F-4E4C-42B4-B7BE-1CB14A818050Q55325868-6BC7170A-1F21-48DF-9004-4188E159CA5EQ57201477-425E18E7-0924-44A9-8706-0B7C374CBADDQ58790980-749950B1-775C-4803-8137-B1C9280CDD33Q58792007-EEEEF44A-21CA-4496-8891-2E09982D391D
P2860
Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prolonged suppression of HBV i ...... n hepatitis B surface antigen.
@en
type
label
Prolonged suppression of HBV i ...... n hepatitis B surface antigen.
@en
prefLabel
Prolonged suppression of HBV i ...... n hepatitis B surface antigen.
@en
P2093
P2860
P1433
P1476
Prolonged suppression of HBV i ...... on hepatitis B surface antigen
@en
P2093
Chang-Ru Wu
Cheng-Pu Sun
James Wk Shih
Jia-Li Cao
Jing-Hua Zhao
Jun-Fang Zhang
Lun-Zhi Yuan
Mi-Hua Tao
Ning-Shao Xia
P2860
P304
P356
10.1136/GUTJNL-2014-308964
P407
P50
P577
2015-09-30T00:00:00Z